Physician profile
Mackenzie Leanne Olson
NPI 1740873413
$2,059.88
in general payments reported to CMS, 2019-2025
16 companies · $1,616 in 2025
The $1,616 reported for 2025 was more than what 90% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $83.52 · 2024: $360 · 2025: $1,616.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,980 · Education: $79.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,979.89 |
| Education | $79.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $658.69 | 2025 | Tremfya |
| Regeneron Healthcare Solutions, INC. | $238.04 | 2025 | Dupixent |
| Amgen INC. | $230.91 | 2025 | Otezla |
| Lilly USA, LLC | $223.00 | 2024-2025 | Ebglyss, Taltz |
| Galderma Laboratories, L.P. | $172.86 | 2025 | Nemluvio |
| Ucb, INC. | $118.57 | 2025 | Bimzelx |
| Merz North America, INC. | $111.37 | 2023-2024 | Xeomin |
| Biofrontera INC. | $94.80 | 2023-2024 | Xepi, Bf-Rhodoled, Ameluz |
| Novartis Pharmaceuticals Corporation | $41.32 | 2025 | |
| Smith+Nephew, INC. | $39.98 | 2024 | Versajet, Collagenase Santyl, Pico |
| Dermavant Sciences, INC. | $27.36 | 2024 | Vtama |
| Organogenesis INC. | $23.77 | 2024 | |
| Abbvie INC. | $22.97 | 2024 | |
| Convatec INC. | $21.78 | 2023 | |
| Integra Lifesciences Corporation | $19.57 | 2025 | Integra, Omnigraft, Integra Dermal Regeneration Template |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paratek Pharmaceuticals, INC. | $14.89 | 2024 | Nuzyra |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mackenzie Olson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.